Global Oncology/Cancer Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Drug Class Type;
Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy) and Hormonal Therapy.Segmented by Indication;
Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer and Other Cancers.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Oncology/Cancer Drugs Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 60.1 |
2021 | 61.2 |
2022 | 66.4 |
2023 | 73.5 |
2024 | 80.3 |
2025 | 90.1 |
2026 | 98.7 |
2027 | 106.9 |
2028 | 114.0 |
2029 | 119.8 |
2030 | 142.5 |
In the year 2023, the Global Oncology/Cancer Drugs Market was valued at USD 168,323.98 million. The size of this market is expected to increase to USD 279,257.76 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.5%.
Global Oncology/Cancer Drugs Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Oncology/Cancer Drugs Market |
Study Period | 2020 - 2030 |
Base Year (for Oncology/Cancer Drugs Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Oncology/Cancer Drugs Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Oncology/Cancer Drugs Market Analysis
In this report, the Global Oncology/Cancer Drugs Market has been segmented by Drug Class Type, Cancer market size by type Indication and Geography. Oncology is a branch of medicine that studies, treats, diagnoses, and prevents cancer. An oncologist is a medical professional who specialises in oncology. The name derives from the Greek word o, which means "tumour," "volume," or "mass."
Global Oncology/Cancer Drugs Market, Segmentation by Drug Class Type
The Global Oncology/Cancer Drugs Market has been segmented by Drug Class Type into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy) and Hormonal Therapy. The complete Global Oncology/Cancer Drugs Market segmentation by Drug Class Type can be seen below:
- Global Oncology/Cancer Drugs Market, By Drug Class Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Drug Class Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Drug Class Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oncology/Cancer Drugs Market, by Drug Class Type (USD Million), 2020 - 2030
# | Chemotherapy | Targeted Therapy | Immunotherapy (Biologic Therapy) | Hormonal Therapy |
---|---|---|---|---|
2020 | 70.2 | 74.0 | 96.3 | 114.9 |
2021 | 76.4 | 75.8 | 106.4 | 125.2 |
2022 | 88.8 | 82.1 | 109.4 | 147.0 |
2023 | 94.3 | 96.1 | 115.5 | 153.6 |
2024 | 97.5 | 108.4 | 130.5 | 159.0 |
2025 | 112.5 | 128.5 | 136.8 | 173.6 |
2026 | 130.7 | 144.1 | 161.1 | 186.3 |
2027 | 150.2 | 146.2 | 174.6 | 196.2 |
2028 | 173.7 | 170.2 | 190.8 | 203.8 |
2029 | 187.9 | 178.2 | 206.1 | 204.9 |
2030 | 198.9 | 180.4 | 219.8 | 216.6 |
Global Oncology/Cancer Drugs Market, Segmentation by Indication
The Global Oncology/Cancer Drugs Market has been segmented by Indication into Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer and Other Cancers. The complete Global Oncology/Cancer Drugs Market segmentation by Indication can be seen below:
- Global Oncology/Cancer Drugs Market, By Indication
- Lung Cancer
- Stomach Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Esophagus Cancer
- Cervical Cancer
- Kidney Cancer
- Bladder Cancer
- Other Cancers
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Indications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Indication is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oncology/Cancer Drugs Market, by Indication (USD Million), 2020 - 2030
# | Lung Cancer | Stomach Cancer | Colorectal Cancer | Breast Cancer | Prostate Cancer | Liver Cancer | Esophagus Cancer | Cervical Cancer | Kidney Cancer | Bladder Cancer | Other Cancers |
---|---|---|---|---|---|---|---|---|---|---|---|
2020 | 58.8 | 62.2 | 61.7 | 68.2 | 66.6 | 94.5 | 77.6 | 78.4 | 106.8 | 77.7 | 78.6 |
2021 | 63.2 | 74.2 | 73.1 | 69.1 | 69.3 | 98.1 | 78.2 | 79.0 | 114.5 | 87.3 | 93.9 |
2022 | 72.9 | 81.8 | 84.2 | 72.3 | 79.8 | 107.7 | 80.9 | 92.3 | 135.0 | 100.0 | 109.6 |
2023 | 73.9 | 81.9 | 89.0 | 73.3 | 95.4 | 117.6 | 84.5 | 100.2 | 157.5 | 120.0 | 112.4 |
2024 | 74.8 | 82.5 | 104.5 | 86.2 | 110.5 | 141.0 | 90.5 | 112.6 | 185.6 | 136.9 | 118.3 |
2025 | 75.1 | 88.2 | 124.3 | 102.7 | 129.4 | 143.2 | 95.0 | 117.0 | 218.6 | 157.4 | 133.5 |
2026 | 84.3 | 94.4 | 137.3 | 112.7 | 131.2 | 153.4 | 109.1 | 118.4 | 221.5 | 177.8 | 152.9 |
2027 | 96.2 | 100.4 | 161.6 | 129.4 | 150.1 | 166.6 | 114.7 | 129.8 | 236.2 | 209.5 | 159.6 |
2028 | 100.3 | 110.0 | 167.3 | 139.1 | 170.9 | 182.4 | 129.2 | 155.1 | 271.0 | 244.1 | 173.7 |
2029 | 117.2 | 115.3 | 192.3 | 162.5 | 186.0 | 213.7 | 148.5 | 182.5 | 322.3 | 290.3 | 198.2 |
2030 | 127.1 | 131.5 | 200.1 | 167.0 | 210.7 | 216.5 | 151.1 | 187.5 | 375.5 | 324.6 | 219.2 |
Global Oncology/Cancer Drugs Market, Segmentation by Geography
In this report, the Global Oncology/Cancer Drugs Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Oncology/Cancer Drugs Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Oncology/Cancer Drugs Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Oncology/Cancer Drugs in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Oncology/Cancer Drugs Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Oncology/Cancer Drugs Market is driven by; Rise in incidence of cancer across the globe, Surge in global geriatric population and Increase in government expenditures on healthcare.
- While the growth of Global Oncology/Cancer Drugs Market is currently hindered by; Adverse effects associated with the use of cancer drugs.
- Global Oncology/Cancer Drugs Market has good growth potential in the future due to the new market opportunities that are being created. The opportunities in this market include; Untapped emerging economies and Increase in number of pipeline drugs.
- Rise in incidence of cancer across the globe.
- Surge in global geriatric population.
- Increase in government expenditures on healthcare.
- Adverse effects associated with the use of cancer drugs.
- Untapped emerging economies.
- Increase in number of pipeline drugs.
Market Opportunity Map
This report provides market opportunity map for Oncology/Cancer Drugs Market. The opportunity map (by market segments; Drug Class Type and Indication) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Oncology/Cancer Drugs Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Oncology/Cancer Drugs Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Oncology/Cancer Drugs Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Oncology/Cancer Drugs Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Oncology/Cancer Drugs Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Oncology/Cancer Drugs Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Oncology/Cancer Drugs Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Oncology/Cancer Drugs Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Oncology/Cancer Drugs Market include, AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, F. HOFFMANN-LA ROCHE LTD., JOHNSON & JOHNSON, Merck & Co., Inc., Novartis AG and Pfizer Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Drug Class Type
- Market Snapshot, By Indication
- Market Snapshot, By Region
- Market Opportunity Map
- Global Oncology/Cancer Drugs Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rise in incidence of cancer across the globe
- Surge in global geriatric population
- Increase in government expenditures on healthcare
- Restraints
- Adverse effects associated with the use of cancer drugs
- Opportunities
- Untapped emerging economies
- Increase in number of pipeline drugs
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Oncology/Cancer Drugs Market, By Drug Class Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Immunotherapy (Biologic Therapy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hormonal Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Chemotherapy
- Global Oncology/Cancer Drugs Market, By Indication, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Stomach Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Esophagus Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Cervical Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Kidney Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Other Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Lung Cancer
- Global Oncology/Cancer Drugs Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Oncology/Cancer Drugs Market, By Drug Class Type, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- AbbVie Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Astellas Pharma Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AstraZeneca PLC
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bristol-Myers Squibb Company
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Celgene Corporation
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. HOFFMANN-LA ROCHE LTD.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- JOHNSON & JOHNSON
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck & Co., Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novartis AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Pfizer Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AbbVie Inc.
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Ophthalmoscopes Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Operating Room Management Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Ophthalmic Refractometer Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Ophthalmic Viscosurgical Devices (OVD) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%